Product: Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg, a) 30 count blister    (NDC 66582-323-30), b) 90 count blister  (NDC 66582-323-54), Rx only, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc, Whitehouse Station, NJ 08889
Reason for recall: Defective Container; some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.
Recall initiated: 20140113
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated